Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03260621
Other study ID # 35/8/15
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 16, 2017
Est. completion date September 1, 2020

Study information

Verified date November 2020
Source University of Göttingen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients of the University Hospital Göttingen with echocardiographic signs for diastolic heart failure and indication for right heart catheterisation will undergo additional diagnostic testing with CMR including exercise stress for detailed evaluation of diastolic dysfunction and tissue characterisation correlating the results with well-established clinical standards.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date September 1, 2020
Est. primary completion date September 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adult patients with dyspnoea under stress, echocardiographic criteria for diastolic dysfunction (E/E'>8) and clinical indication for right heart catheterisation Exclusion Criteria: - arrhythmia (brady- or tachycardic) - bronchial asthma (allergic) - incompliant patient - pacemaker, ICD, non MRI-capable devices - inability to use the ergometer in the MRI - haemodynamic relevant valvular heart disease - pulmonary disease (vital capacity or forced expiratory flow <80% of healthy control) - angina pectoris - post cardiac infarction - anaemia (Hb <12 g/dl) - uncontrollable hypertension (>150 mmHg systolic or >100 mmHg diastolic) - age <18 years - pregnancy - claustrophobia - renal insufficiency - allergic to gadolinium based contrast agents

Study Design


Intervention

Diagnostic Test:
stress CMR
additional stress CMR to the established clinical diagnostics

Locations

Country Name City State
Germany University Hospital Goettingen Göttingen

Sponsors (2)

Lead Sponsor Collaborator
University of Göttingen Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other Exercise spirometry maximal oxygen uptake approx. 1 years
Other Exercise spirometry respiratory quotient approx. 1 years
Other Exercise spirometry power (watt/kg) approx. 1 years
Other Right heart catheterization reference for intracardiac pressures: pulmonary artery pressure and pulmonary capillary wedge pressure approx. 1 years
Primary Cardiovascular magnetic resonance imaging ventricular and atrial volumes approx. 1 years
Primary Cardiovascular magnetic resonance imaging ventricular and atrial mechanics: strain approx. 1 years
Primary Cardiovascular magnetic resonance imaging quantification of extracellular volume (ECV)/interstitial fibrosis approx. 1 years
See also
  Status Clinical Trial Phase
Recruiting NCT02499601 - CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) N/A
Completed NCT02537041 - Non-invasive Evaluation of Myocardial Stiffness by Elastography N/A
Completed NCT02275793 - The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
Withdrawn NCT00773084 - Aliskiren and Renin Inhibition in Diastolic Heart Failure N/A
Terminated NCT00293150 - Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure Phase 4
Terminated NCT01942395 - Dietary Approaches to Stop Hypertension in 'Diastolic' Heart Failure 2 (DASH-DHF 2) N/A
Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
Terminated NCT01778894 - Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart
Completed NCT04154878 - 2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).
Recruiting NCT01599117 - A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF] Phase 3
Completed NCT01185067 - Physiological Effects of Grape Seed Extract in Diastolic Heart Failure Phase 1
Completed NCT03338374 - Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failure With Preserved Ejection Fraction N/A
Completed NCT02589977 - Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF Phase 4
Completed NCT02147613 - High Intensity Interval Exercise in Diastolic Heart Failure N/A
Terminated NCT00083772 - Use of Nesiritide in the Management of Acute Diastolic Heart Failure Phase 4
Completed NCT00303498 - A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure Phase 2
Terminated NCT02254382 - Positive Airway Pressure Therapy Study in Sleep Apnea and Diastolic Heart Failure N/A
Completed NCT00839228 - Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome Phase 2
Terminated NCT00662116 - Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I) Phase 2
Completed NCT02084992 - A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure N/A